The Cancer Stage Shifting Initiative: Registry and Biorepository
This is an observational study, meaning it doesn't test a specific treatment but rather collects information. Its main goal is to create a large registry (a collection of health information) and a biorepository (a collection of biological samples) to better understand cancer. Researchers want to investigate why some groups of people face more challenges in getting cancer screenings and early detection. This study is open to adults aged 35 and older who are willing to share their health information and demographic data. The study aims to establish this registry and biorepository over 10 years to support future research, especially for communities at higher risk for cancer.
- Study design
- This is an observational study that aims to enroll 100,000 participants. It is not testing any specific intervention.
- What's involved
- You would attend a minimum of five clinic visits over a five-year period for annual assessments.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed from enrollment to the end of follow-up at 10 years.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
The Cancer Stage Shifting Initiative: Registry and Biorepository to Research and Address Health Disparities in Cancer Care
At a glance
Conditions
Where it's being run
2 sites across 2 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Establish a patient registryFrom enrollment to the end of follow up at 10 years.
The primary objective of this study is to establish a patient registry that collects and characterizes health data from marginalized and underserved communities.